Navigation Links
Ampio Pharmaceuticals to Present at Upcoming Investor Conference
Date:11/15/2013

GREENWOOD VILLAGE, Colo., Nov. 15, 2013 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that the company is scheduled to present a corporate update at the following upcoming investor conference:

Piper Jaffray 25th Annual Healthcare Conference
Presentation: Tuesday, December 3, 2013 at 10:10 AM EST at the New York Palace Hotel in New York, New York (Kennedy 1 Room)
Presenting: Michael Macaluso, Chairman & Chief Executive Officer & Dr. Vaughan Clift, Chief Regulatory Affairs Officer

(Logo: http://photos.prnewswire.com/prnh/20120516/MM09116LOGO)

Ampio will webcast this management presentation, and the presentation may be accessed through the Company's website, www.ampiopharma.com, on the "Events and Presentations' page. An archived version of the presentation will be available for 90 days.

About Ampio Pharmaceuticals
Ampio Pharmaceuticals, Inc. is a development stage biopharmaceutical company primarily focused on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. We are developing compounds that decrease inflammation by (i) inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; (ii) activating specific phosphatase or depletion of the available phosphate needed for the inflammation process; and (iii) decreasing vascular permeability.

Investor Contact:
Rick Giles
Director of Investor Relations
Ampio Pharmaceuticals, Inc.
Direct (720) 437-6530
Email: rgiles@ampiopharma.com


'/>"/>
SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ampio Pharmaceuticals, Inc. States that its Policy is Not to Comment on Unusual Market Activity
2. Ampio Pharmaceuticals subsidiary Luoxis Diagnostics announces positive summary data from study of traumatic brain injury patients and issuance of companys third US patent for its oxidation-reduction potential diagnostic platform
3. Ampio Pharmaceuticals, Inc. Announces Additional Positive Results for Ampion(TM) in Osteoarthritis of the Knee Clinical Trial
4. Ampio Pharmaceuticals, Inc. Announces $25 Million Financing
5. Astellas to Host Executive Womens Day at 2013 TOUR Championship by Coca-Cola
6. Ampio Pharmaceuticals, Inc. Announces Positive Results for Ampion in Osteoarthritis of the Knee Clinical Trial
7. Levine Leichtman Acquires Champion Manufacturing
8. Pro Athletes Team Up to Champion Gout Awareness
9. Dr. Helen Fisher to Speak at Astellas Presents Executive Womens Day at the Constellation SENIOR PLAYERS Championship
10. Ampio Pharmaceuticals Issues Statement Regarding Misleading Blog
11. Ampio Pharmaceuticals to List on the NYSE MKT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2019)... ... December 06, 2019 , ... Nobilis Therapeutics , a ... disorders, announced today that the U.S. Food and Drug Administration (FDA) has cleared ... initiate its Phase 2b trial for the treatment of patients with Posttraumatic Stress ...
(Date:12/6/2019)... ... December 06, 2019 , ... ... Forbidden Fruit Garden Supply LLC (a division of Horticultural Holdings LLC) to recommend ... professional growers. , FFGS is a team of disciplined and energetic plant ...
(Date:12/5/2019)... ... December 05, 2019 , ... nView, a leading ... to the role of Chief Product Officer. As the company expands its portfolio ... of the behavioral health market into nView’s product and company growth strategy. Rosenbaum ...
Breaking Medicine Technology:
(Date:12/14/2019)... , ... December 13, 2019 , ... ... planning, has announced the Top 15 Master's in Child Development Degree Programs for ... colleges and universities in the nation. Each program is evaluated based on curriculum ...
(Date:12/9/2019)... ... December 09, 2019 , ... Greenlight Guru, quality management ... platform’s - - Change Management capabilities . The enhanced Change Management capabilities ... items impacted by change orders in a collaborative change workspace, while also ensuring ...
(Date:12/8/2019)... ... December 07, 2019 , ... Intelligent.com, a trusted resource for ... Master of Science in Nursing (MSN) Degree Programs for 2020. The comprehensive research ... the nation. Each program is evaluated based on curriculum quality, graduation rate, reputation, ...
(Date:12/6/2019)... ... December 06, 2019 , ... Connecticut is home ... excellence in patient care. On December 12th, Hartford Business Journal will recognize eight ... Care Heroes Awards at the Hartford Marriott. , “We are fortunate to have ...
(Date:12/6/2019)... ... 06, 2019 , ... Brain Sentinel, Inc. announces it is ... AES Annual Meeting. The symposium, “Fundamentals of Quantitative Surface Electromyography (sEMG) for Long-Term ... analysis during ictal events;, 2. Review specific sEMG patterns of motor seizures and ...
Breaking Medicine News(10 mins):